How to buy dabrafenib/dabrafenib? Domestic and foreign purchasing channels and precautions

Dabrafenib has been approved as a drug in China and has been included in the medical insurance catalog. It is mainly suitable for the treatment of melanoma, thyroid cancer, non-small cell lung cancer and other diseases. In the domestic market, the original drug of dabrafenib is produced by Novartis. Its specifications include50 mg and 75 mg, and is packaged in 120 capsules/bottle. The price of each box is usually around RMB 10,000, which may be a heavy burden for some patients. Due to the high price of medicines, some patients choose to purchase them through other channels, especially through overseas markets.

Overseas, especially in countries with lower drug prices such as Türkiye, the price of dabrafenib is more affordable than in China. Take 75 mg dabrafenib in 120-pellet form as an example. Its original drug price in Turkey is about more than 7,000 yuan. However, it should be noted that purchasing drugs overseas may be affected by exchange rate fluctuations and prices may vary, so these factors should be taken into consideration when purchasing.

In addition to the original drug, there are also a variety of generic drugs of dabrafenib on the market, especially those produced in lower-cost production countries such as Laos. The price of medicines of the same specifications produced in Laos is about more than 2,000 yuan, which is more affordable than original medicines. However, although the ingredients and efficacy of generic drugs are similar to the original drugs, you need to pay attention to the quality and regularity of the drugs when purchasing. Make sure you purchase through legal channels to avoid buying counterfeit medicines or products of substandard quality.

In addition, when purchasing dabrafenib, patients should also consult their doctors to ensure the quality, dosage and usage of the drug are correct. When purchasing, be sure to ask for formal invoices and quality certificates to avoid drug quality issues affecting the therapeutic effect.

Reference materials:https://go.drugbank.com/drugs/DB08912